BSX vs XBIO · P/E 20, rev $10.65B vs rev $1.5M
Boston Scientific Corp (BSX) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the BSX and XBIO stock pages for the full models.
Not investment advice.